Cargando…

Triple Primary Malignancies: Tumor Associations, Survival, and Clinicopathological Analysis: A 25-Year Single-Institution Experience

The detection of multiple primary malignancies is on the rise despite their rare occurrence rate. This research aims to determine the prevalence, tumor association patterns, overall survival, and the correlation between survival time and independent factors in patients with triple primary malignanci...

Descripción completa

Detalles Bibliográficos
Autores principales: Almasan, Iulia, Piciu, Doina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001057/
https://www.ncbi.nlm.nih.gov/pubmed/36900742
http://dx.doi.org/10.3390/healthcare11050738
_version_ 1784904039190757376
author Almasan, Iulia
Piciu, Doina
author_facet Almasan, Iulia
Piciu, Doina
author_sort Almasan, Iulia
collection PubMed
description The detection of multiple primary malignancies is on the rise despite their rare occurrence rate. This research aims to determine the prevalence, tumor association patterns, overall survival, and the correlation between survival time and independent factors in patients with triple primary malignancies. This single-center retrospective study included 117 patients with triple primary malignancies admitted to a tertiary cancer center between 1996 and 2021. The observed prevalence was 0.082%. The majority of patients (73%) were over the age of fifty at the first tumor diagnosis, and regardless of gender, the lowest median age occurred in the metachronous group. The most common tumor associations were found between genital–skin–breast, skin–skin–skin, digestive–genital–breast, and genital–breast–lung cancer. The male gender and being over the age of fifty at the first tumor diagnosis are associated with a higher risk of mortality. Compared with the metachronous group, patients with three synchronous tumors demonstrate a risk of mortality 6.5 times higher, whereas patients with one metachronous and two synchronous tumors demonstrate a risk of mortality three times higher. The likelihood of subsequent malignancies should always be considered throughout cancer patients’ short- and long-term surveillance to ensure prompt tumor diagnosis and treatment.
format Online
Article
Text
id pubmed-10001057
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100010572023-03-11 Triple Primary Malignancies: Tumor Associations, Survival, and Clinicopathological Analysis: A 25-Year Single-Institution Experience Almasan, Iulia Piciu, Doina Healthcare (Basel) Article The detection of multiple primary malignancies is on the rise despite their rare occurrence rate. This research aims to determine the prevalence, tumor association patterns, overall survival, and the correlation between survival time and independent factors in patients with triple primary malignancies. This single-center retrospective study included 117 patients with triple primary malignancies admitted to a tertiary cancer center between 1996 and 2021. The observed prevalence was 0.082%. The majority of patients (73%) were over the age of fifty at the first tumor diagnosis, and regardless of gender, the lowest median age occurred in the metachronous group. The most common tumor associations were found between genital–skin–breast, skin–skin–skin, digestive–genital–breast, and genital–breast–lung cancer. The male gender and being over the age of fifty at the first tumor diagnosis are associated with a higher risk of mortality. Compared with the metachronous group, patients with three synchronous tumors demonstrate a risk of mortality 6.5 times higher, whereas patients with one metachronous and two synchronous tumors demonstrate a risk of mortality three times higher. The likelihood of subsequent malignancies should always be considered throughout cancer patients’ short- and long-term surveillance to ensure prompt tumor diagnosis and treatment. MDPI 2023-03-02 /pmc/articles/PMC10001057/ /pubmed/36900742 http://dx.doi.org/10.3390/healthcare11050738 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Almasan, Iulia
Piciu, Doina
Triple Primary Malignancies: Tumor Associations, Survival, and Clinicopathological Analysis: A 25-Year Single-Institution Experience
title Triple Primary Malignancies: Tumor Associations, Survival, and Clinicopathological Analysis: A 25-Year Single-Institution Experience
title_full Triple Primary Malignancies: Tumor Associations, Survival, and Clinicopathological Analysis: A 25-Year Single-Institution Experience
title_fullStr Triple Primary Malignancies: Tumor Associations, Survival, and Clinicopathological Analysis: A 25-Year Single-Institution Experience
title_full_unstemmed Triple Primary Malignancies: Tumor Associations, Survival, and Clinicopathological Analysis: A 25-Year Single-Institution Experience
title_short Triple Primary Malignancies: Tumor Associations, Survival, and Clinicopathological Analysis: A 25-Year Single-Institution Experience
title_sort triple primary malignancies: tumor associations, survival, and clinicopathological analysis: a 25-year single-institution experience
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001057/
https://www.ncbi.nlm.nih.gov/pubmed/36900742
http://dx.doi.org/10.3390/healthcare11050738
work_keys_str_mv AT almasaniulia tripleprimarymalignanciestumorassociationssurvivalandclinicopathologicalanalysisa25yearsingleinstitutionexperience
AT piciudoina tripleprimarymalignanciestumorassociationssurvivalandclinicopathologicalanalysisa25yearsingleinstitutionexperience